ID: h-SDA-2026-04-26-gap-debate-20260426-011
Hypothesis

Calcium-Dependent S100B Release from Astrocyte End-Feet as an Early Signal of Astrocyte-Mediated BBB Dysfunction

S100B is released from astrocytes upon inflammatory activation or metabolic stress, causing pericyte dysfunction and endothelial tight junction disruption.
🧬 S100B (S100 Calcium Binding Protein B)🎯 Composite 72%💱 $0.57▼16.0%proposed
neurodegeneration
EvidencePending (0%)📖 8 cit🗣 1 debates 8 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.71 (15%) Evidence 0.49 (15%) Novelty 0.45 (12%) Feasibility 0.43 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.55 (8%) Competition 0.00 (6%) Data Avail. 0.10 (5%) Reproducible 0.70 (5%) KG Connect 0.50 (8%) 0.725 composite
🏆 ChallengeResolve: Calcium-Dependent S100B Release from Astrocyte End-Feet as an Early Sig$500 →

🧪 Overview

S100B is released from astrocytes upon inflammatory activation or metabolic stress, causing pericyte dysfunction and endothelial tight junction disruption. Elevated serum S100B precedes measurable amyloid or tau pathology. Major advantage: S100B is already FDA-cleared/IVD-registered for traumatic brain injury, providing established clinical laboratory infrastructure and assay standardization. This dramatically reduces development costs and timeline for AD adaptation.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
A["Calcium influx in astrocytes"]
B["S100B release from astrocyte end-feet"]
C["Pericyte contraction and dysfunction"]
D["Endothelial tight junction disruption"]
E["Blood-brain barrier dysfunction"]
F["Elevated serum S100B"]
G["Cognitive decline onset"]
H["Amyloid and tau pathology progression"]

A -->|"triggers"| B
B -->|"acts on"| C
C -->|"promotes"| D
D -->|"causes"| E
E -->|"results in"| F
B -->|"precedes"| H
E -->|"leads to"| G
G -->|"accelerates"| H

style A fill:#4fc3f7,color:#0d0d1a
style B fill:#4fc3f7,color:#0d0d1a
style C fill:#ef5350,color:#0d0d1a
style D fill:#ef5350,color:#0d0d1a
style E fill:#ef5350,color:#0d0d1a
style F fill:#ffd54f,color:#0d0d1a
style G fill:#ef5350,color:#0d0d1a
style H fill:#ef5350,color:#0d0d1a

⚖️ Evidence

⚖️ Evidence Matrix8 supports3 contradicts
Supports
S100B established as marker of glial dysfunction in AD
Supports
Serum S100B elevation precedes cognitive decline in elderly
Supports
S100B release causes pericyte contraction and BBB leakiness
Supports
An update on diagnostic and prognostic biomarkers for traumatic brain injury.
Expert Rev Mol Diagn2018PMID:29338452medium
Supports
Early microglial and astrocyte reactivity in preclinical Alzheimer's disease.
Alzheimers Dement2025PMID:40747577medium
Supports
High-dimensional proteomic analysis for pathophysiological classification of traumatic brain injury.
Brain2025PMID:39323289medium
Supports
Data-driven CSF biomarker profiling: imaging and clinical outcomes in a cohort at risk of Alzheimer's disease.
Alzheimers Res Ther2024PMID:39716329medium
Supports
Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Neurol Sci2013PMID:22526766medium
Contradicts
S100B shows circadian rhythm and is significantly affected by physical activity
Contradicts
Serum S100B showed no independent predictive value for AD conversion after controlling for general inflammation
Contradicts
S100B expressed in multiple non-CNS sources including adipocytes and skeletal muscle
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — S100B

No curated PDB or AlphaFold mapping for S100B yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for S100B (S100 Calcium Binding Protein B) from GTEx v10.

Spinal cord cervical c-13318 Substantia nigra1111 Cerebellum464 Hypothalamus463 Hippocampus458 Amygdala378 Cerebellar Hemisphere370 Nucleus accumbens basal ganglia329 Putamen basal ganglia306 Anterior cingulate cortex BA24306 Caudate basal ganglia285 Frontal Cortex BA9278 Cortex261median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for S100B (S100 Calcium Binding Protein B) →

No DepMap CRISPR Chronos data found for S100B (S100 Calcium Binding Protein B).

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 1.1%
Volatility
Medium
0.0377
Events (7d)
3
Price History
▼16.0%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations1 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
If astrocytic S100B release at end-feet is calcium-dependent and early indicator of BBB dysfunction, then elevated plasma S100B will precede and predict BBB breakdown (measured by Qalb and DCE-MRI) inIn 2-year longitudinal study (n≥100), baseline plasma S100B in top quartile predicts subsequent Qalb elevation (OR>4) and DCE-MRI Ktrans reduction within 12-18 — no observation —pending0.73
🔮 Falsifiable Predictions (1)
pendingconf —
If astrocytic S100B release at end-feet is calcium-dependent and early indicator of BBB dysfunction, then elevated plasma S100B will precede and predict BBB breakdown (measured by Qalb and DCE-MRI) in early neurodegeneration, independent of astrocyte reactivity (GFAP) and neuronal injury (NfL).
Predicted outcome: In 2-year longitudinal study (n≥100), baseline plasma S100B in top quartile predicts subsequent Qalb elevation (OR>4) and DCE-MRI Ktrans reduction wit
Falsification: Plasma S100B does not predict BBB breakdown; S100B changes occur after or simultaneously with Qalb changes, and are explained entirely by concurrent GFAP and NfL changes, indicating S100B is a downstr
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.